Pre- and post-procedure instructions for microdermabrasion
Pre-procedure instructions
Two days prior to treatment, discontinue using all alpha hydroxy acid products (those containing glycolic or lactic acid), salicylic acid products, retinoids (Retin A, Renova, Differin and Tazorac) and other topical acne medications such as benzoyl peroxide. If in doubt about using any product, please discontinue it and discuss with the nurse at your appointment.
The following procedures should not be performed for a minimum of 7 days before microdermabrasion:
NOTE: If you have a history of herpes simplex virus (cold sores or fever blisters), in rare instances a reactivation of this condition could occur after treatment. Please inform your nurse or physician so that an anti-viral medication can be prescribed before the treatment.
Post-procedure instructions
Cleanse and moisturize your skin twice daily.
Do not use any alpha hydroxy acid products (those containing glycolic or lactic acid), salicylic acid products, retinoids (Retin A, Renova, Differin and Tazorac) and other topical acne medications such as benzoyl peroxide for 72 hours after the treatment.
Do not directly expose the treated area to the sun for at least 48 hours after the treatment. Use a sunscreen every day that blocks both UVA and UVB rays, preferably one containing zinc or titanium dioxide which should not irritate the skin.
The following procedures should not be performed for a minimum of 7 days after microdermabrasion:
If you do undergo these procedures after the 7 day waiting period, notify the appropriate person that you have had microdermabrasion.
The following is a partial list of ingredients that you should avoid for 72 hours after microdermabrasion:
Recommended products which will enhance your response to the treatment:
If you have any questions, please do not hesitate to call our office at (203) 792-4151 in Danbury.
![]()
Legal disclaimer/website privacy policies
Copyright © 2007. Dermatology Associates of Western Connecticut, PC
All rights reserved. This website is best viewed in Firefox 1.5 or above, Internet Explorer 6.0 or above,
or Safari 2.0 or above.